PageBlaster
by American Printing House for the Blind
Price is what the vendor listed when last checked. Confirm it with the vendor before buying.
What it is
Summary
AI-generated from vendor-published content · October 1, 2026
The PageBlaster is a braille embosser, a printer that punches raised braille dots into paper instead of printing ink. It feeds continuous fanfold paper, so you can run longer documents without loading single sheets. It comes with TactileView drawing software for making tactile graphics. This is a good fit for a classroom or home where someone needs braille copies of documents.
Getting it
Try before you buy
Devices like this are often available to borrow through your state's AT Act program — typically free or low-cost — so you can try it before buying or pursuing funding.
Where to get it
This is the vendor WhatCanHelp tracks for this product — it may also be available from other retailers or a local supplier, and prices vary.
How to fund this
These are common places to ask about paying for equipment like this. Each one decides its own eligibility and what it covers, so start by asking them.
Details
Quick Facts Catalog facts · auto-generated
- Type
- Addresses
- Platform
- Age range
- Complexity
- Setup with instructions
- Price
- $4,295.00
- Funding
- AT Act lending
- Out of pocket
- School district
- Vocational rehab
What setup looks like
- Out of the box
Unbox the embosser and place it on a sturdy surface, ideally one with room around it for the paper feed. - With a guide
- Load the fanfold paper and connect the embosser to your computer.
- Install the TactileView drawing software and send a test page to check the braille output.
- Watch the training tutorial videos on the product page to learn everyday use. Plan on about an hour to get comfortable.
Compare & explore
Sources & fine print
Vendor facts (name, price, platforms, vendor link) sourced from American Printing House for the Blind — view on vendor site (opens in a new tab); last checked November 1, 2026.
Classification & description AI-generated from vendor-published content on October 1, 2026 · confidence: medium. Vendor specs may lag; verify before relying on details in a clinical or funding artifact.